Search results
23 kwi 2021 · CCR5 gene is now being treated as a viable target for HIV treatment. It can be used in the treatment of HIV either through administration of drugs that bind to CCR5 and stop the receptor from working or through gene therapy to alter the CCR5 gene using CRISPR/Cas9 and prevent protein production.
10 lip 2024 · New HIV drug can only offer hope of ending AIDS if all have access, UNAIDS says. GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences’ trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention.
16 lip 2021 · These guidelines bring in the most recent guidance on HIV testing strategies - the entry point for HIV prevention and treatment - and include comprehensive guidance on infant diagnosis. Key recommendations are presented on rapid antiretroviral therapy (ART) initiation and the use of dolutegravir.
22 lip 2024 · By 2025, 95% of all people living with HIV should have a diagnosis, 95% of whom should be taking lifesaving antiretroviral treatment, and 95% of people living with HIV on treatment should achieve a suppressed viral load for the benefit of the person’s health and for reducing onward HIV transmission.
21 cze 2023 · In this Review, we summarize the current state of the art for HIV prevention and treatment, focusing on the unmet needs. We then discuss the emerging arsenal of tools that address these unmet...
Today, clinical treatment guidelines from the US Department of Health and Human Services (DHHS) include certain STRs as recommended initial treatment regimen options for most people living with...
30 lis 2020 · Five factors drive the need for an HIV cure: improving ART access and adherence; enhancing quality of life of people living with HIV; preventing new infections; combating stigma and discrimination; and ensuring financial and programmatic sustainability and scalability.
